Atlantic Equities analyst Steve Chesney maintains Biogen (NASDAQ:BIIB) with a Neutral and raises the price target from $220 to $295.
What’s Going On With Chewy Stock?
Chewy shares are trading higher Tuesday, and the stock is up more than 60% over the past month. Here's a look at what to know:
